Latest KFF Health News Content

Latest KFF Health News Stories

Freedom Caucus Leaders Appear Ready To Support Revised GOP Health Plan

Morning Briefing

Conservatives seem to be coalescing behind a health plan that includes waivers allowing states to opt out of major regulations related to essential health benefits and insurance companies to charge higher premiums for patients with preexisting conditions.

5 Things To Know About The Subsidies At The Heart Of A Capitol Hill Battle

KFF Health News Original

Democrats want a bill to fund the government for the rest of the year to include funding for the health law’s cost-sharing reductions for low-income marketplace customers, but Republicans want to keep the issues separate.

Pre-Obamacare, Preexisting Conditions Long Vexed States And Insurers

KFF Health News Original

Before the federal health law guarantee that consumers cannot be turned down because of their medical history, it was difficult to balance insurers’ needs to make a profit and individuals’ needs for coverage.

Health Care Worries Pull Crowd To Conservative Ohio Rep’s Town Hall

KFF Health News Original

Rep. Jim Jordan, R-Ohio, sparked discord at his meeting with his district’s voters Monday when he suggested churches, schools and families are best able to handle the opioid epidemic rather than the federal government.

50 Years Ago, Colorado ‘Pushed On A Half-Open Door’ And Became First State To Loosen Abortion Rules

Morning Briefing

In 1967, state Rep. Richard Lamm introduced legislation that would make abortion legal beyond cases when the woman’s life was at stake. Media outlets also report on abortion news out of Illinois, Minnesota and Tennessee.

Cases Of Malaria At U.S. Hospitals Higher Than Expected

Morning Briefing

Experts believe immigrants and travelers, who have lost their childhood immunity by living in America for some time, are returning to their home countries not expecting to need protection from the disease. Then they come back to the U.S. infected.

These Patients Weren’t Expected To Survive, But In Doing So They Changed The Trajectory Of Medicine

Morning Briefing

Stat talks with Dr. Brian J. Druker and his patients who were some of the first to be shifted away from a scorched-earth treatment of cancer to precision medicine. In other public health news: mapping the brain’s neurons, the dangers of nursery products, long-term birth control, genital mutilation and more.

FDA Nominee Played Role In Pushing More Fentanyl Into Circulation, Critics Claim

Morning Briefing

Scott Gottlieb’s part in getting Cephalon, a company that makes lollipops for cancer patients in extreme pain, more opioids lends itself to established concerns that the Trump administration’s pick to head the Food and Drug Administration is too closely tied to the drug industry. In other news on the opioid epidemic, special schools are helping teens stay sober and the use of painkillers in the middle-aged and elderly is skyrocketing.

Physicians Seek Modifications In Medicare’s New Plans For Payment

Morning Briefing

The doctors are hoping that in rules expected soon the federal government will ease requirements for small practices to participate in the new Medicare payment options offering higher risk and higher financial reward. Also, some hospitals are asking the federal government to make some bundled-payment programs voluntary.

Gov. Walker Seeks To Make Wisconsin First State To Impose Drug Testing For Medicaid

Morning Briefing

Critics are mobilizing against the screening and testing requirement because they say it could unfairly stigmatize the poor and complicate an already difficult application process. News outlets also report on Medicaid news from Arkansas and Ohio.

Sanofi Claims Mylan Artificially Bumped Up EpiPen Prices, Then Undercut Competition With Rebates

Morning Briefing

The drugmaker filed a lawsuit against the troubled EpiPen-maker on Monday. In other pharmaceutical news, The Daily Beast investigates the involvement of Rep. Chris Collins, R-N.Y., with an Australian biotech company, a panel of U.S. scientists is questioning the methodology of an Ebola drug trial, Biogen releases the promising results of a drug to help children with a neuromuscular disease, and one California lawmaker has a plan for lowering drug prices.